These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 20297863)

  • 21. [Isotretinoin in childbearing women: compliance with strengthen warnings].
    Autret-Leca E; Jonville-Béra AP; Szafir D; Cissoko H; Boulkroun Y; Goehrs JM
    Ann Dermatol Venereol; 2000 Oct; 127(10):808-13. PubMed ID: 11060382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased prescribing of systemic tetracyclines and isotretinoin for treatment of acne.
    Odsbu I; Selmer R; Stålsby Lundborg C; Blix HS
    J Antimicrob Chemother; 2017 May; 72(5):1510-1515. PubMed ID: 28158436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of acne by isotretinoin (general course)].
    Chivot M
    Rev Prat; 2002 Apr; 52(8):845-9. PubMed ID: 12053792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Provision of potentially teratogenic medications to female veterans of childbearing age.
    Schwarz EB; Longo LS; Zhao X; Stone RA; Cunningham F; Good CB
    Med Care; 2010 Sep; 48(9):834-42. PubMed ID: 20706159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies.
    Lagan BM; Dolk H; White B; Uges DR; Sinclair M
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):411-8. PubMed ID: 24493556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compliance with Pregnancy Prevention Recommendations for Isotretinoin in Estonia in 2012-2016.
    Uusküla A; Pisarev H; Kurvits K; Laius O; Laanpere M; Uusküla M
    Drugs Real World Outcomes; 2018 Jun; 5(2):129-136. PubMed ID: 29790022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pregnancy after isotretinoin use].
    Manders KC; de Vries LC; Roumen FJ
    Ned Tijdschr Geneeskd; 2013; 157(41):A6567. PubMed ID: 24103139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electronic e-isotretinoin prescription chart: improving physicians' adherence to isotretinoin prescription guidelines.
    Tang MB; Tan ES; Tian EA; Loo SC; Chua SH
    Australas J Dermatol; 2009 May; 50(2):107-12. PubMed ID: 19397562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Pharmacist Prescription With Dispensed Duration of Hormonal Contraception.
    Rodriguez MI; Edelman AB; Skye M; Anderson L; Darney BG
    JAMA Netw Open; 2020 May; 3(5):e205252. PubMed ID: 32432710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isotretinoin therapy for acne: a population-based study.
    Hogan DJ; Strand LM; Lane PR
    CMAJ; 1988 Jan; 138(1):47-50. PubMed ID: 2961430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies.
    Crijns I; Straus S; Luteijn M; Gispen-de Wied C; Raine J; de Jong-van den Berg L
    Drug Saf; 2012 Jan; 35(1):27-32. PubMed ID: 22050373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isotretinoin exposure during pregnancy: a population-based study in The Netherlands.
    Zomerdijk IM; Ruiter R; Houweling LM; Herings RM; Sturkenboom MC; Straus SM; Stricker BH
    BMJ Open; 2014 Nov; 4(11):e005602. PubMed ID: 25392022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contraceptive use in acne.
    Lam C; Zaenglein AL
    Clin Dermatol; 2014; 32(4):502-15. PubMed ID: 25017461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pregnancy-prevention program in women of childbearing age receiving isotretinoin.
    Mitchell AA; Van Bennekom CM; Louik C
    N Engl J Med; 1995 Jul; 333(2):101-6. PubMed ID: 7777014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adult female acne treated with spironolactone: a retrospective data review of 70 cases.
    Isvy-Joubert A; Nguyen JM; Gaultier A; Saint-Jean M; Le Moigne M; Boisrobert E; Khammari A; Dreno B
    Eur J Dermatol; 2017 Aug; 27(4):393-398. PubMed ID: 28862134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy.
    Henry D; Dormuth C; Winquist B; Carney G; Bugden S; Teare G; Lévesque LE; Bérard A; Paterson JM; Platt RW;
    CMAJ; 2016 Jul; 188(10):723-730. PubMed ID: 27114489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isotretinoin, Patient Safety, and Patient-Centered Care-Time to Reform iPLEDGE.
    Barbieri JS; Frieden IJ; Nagler AR
    JAMA Dermatol; 2020 Jan; 156(1):21-22. PubMed ID: 31664426
    [No Abstract]   [Full Text] [Related]  

  • 38. Prescription of teratogenic medications in United States ambulatory practices.
    Schwarz EB; Maselli J; Norton M; Gonzales R
    Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women.
    Schwarz EB; Postlethwaite DA; Hung YY; Armstrong MA
    Ann Intern Med; 2007 Sep; 147(6):370-6. PubMed ID: 17876020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic inertia during isotretinoin treatment of juvenile acne by dermatologists, paediatricians and general practitioners.
    Mahé E; Werner A; Cret L; Salinier C; Guellich A; Maruani A; Assathiany R;
    Ann Dermatol Venereol; 2023 Mar; 150(1):39-45. PubMed ID: 36642678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.